1. Home
  2. GRDN vs BCRX Comparison

GRDN vs BCRX Comparison

Compare GRDN & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardian Pharmacy Services Inc.

GRDN

Guardian Pharmacy Services Inc.

HOLD

Current Price

$38.88

Market Cap

2.3B

ML Signal

HOLD

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$8.96

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRDN
BCRX
Founded
2004
1986
Country
United States
United States
Employees
3600
N/A
Industry
Retail-Drug Stores and Proprietary Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.3B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
GRDN
BCRX
Price
$38.88
$8.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
11
Target Price
$40.60
$20.82
AVG Volume (30 Days)
355.8K
4.7M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
381.40
EPS
N/A
N/A
Revenue
N/A
$25,186,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.63
$12.55
P/E Ratio
$117.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.17
$6.00
52 Week High
$41.36
$11.31

Technical Indicators

Market Signals
Indicator
GRDN
BCRX
Relative Strength Index (RSI) 58.29 49.25
Support Level $31.74 $8.36
Resistance Level $39.62 $9.90
Average True Range (ATR) 1.43 0.41
MACD 0.26 0.01
Stochastic Oscillator 77.08 44.74

Price Performance

Historical Comparison
GRDN
BCRX

About GRDN Guardian Pharmacy Services Inc.

Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: